Investors concerned over Synergy's health
Provider of sterilisation services, Synergy Health, saw both revenue and profit rise for the six months ended 2 October, but shares fell lower on Thursday after the firm gave an uncertain outlook on the healthcare market.
Provider of sterilisation services, Synergy Health, saw both revenue and profit rise for the six months ended 2 October, but shares fell lower on Thursday after the firm gave an uncertain outlook on the healthcare market.
Like-for-like revenue rose 11.9% from £138.7m to £155.3m, while pre-tax profit was £16.6m, up 11.1% from the same period last year. Meanwhile, net debt grew from £117.5m to £149.2m, while operating cash flow dipped slightly from £38.4m to £36.1m.
However, Synergy did warn that the current economic climate in the UK and Europe has created "increased cost awareness", having an impact on publicly funded healthcare markets: "This more challenging economic environment will ultimately have a positive impact on the rate of outsourcing, but whilst we have a period of uncertainty, customer decision making can be slow."
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Nevertheless, chief executive Richard Steeves remained confident that the group can achieve its full-year targets.
"We continue to make good progress with our strategy of developing Synergy's international presence in outsourced sterilisation services to hospitals and medical device manufacturers," he said. "The relatively resilient nature of the healthcare sector, our strong market position and barriers to entry, position us well to maintain growth."
The board will pay an interim dividend of 6.82p per share, up 13.7% on the same period last year (2010: 6p).
The share price fell 1.16% to 810.5p by 08:39.
NR
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Millions at risk of 'unnecessary' tax bill – how to shield your savingsMillions of Brits could be taxed on their savings interest this year as their savings interest exceeds the personal savings allowance. Are you at risk?
-
Savers will have to wait as long as 48 years to build a £1m cash ISA pot if allowance is cutChancellor Rachel Reeves is rumoured to be planning a cut to the cash ISA allowance in the Autumn Budget, making it harder for savers to build wealth. Will you still be able to build a £1 million cash ISA pot?
